Small Molecule Targeted Cancer Therapy Market by Type (Small Molecule Drug Conjugates, Small Molecules and Monoclonal Antibodies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

17-Feb-2020 | Number of pages: 110 | Report Code: ZMR-5253 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the small molecule targeted cancer therapy market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the small molecule targeted cancer therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the small molecule targeted cancer therapy market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the small molecule targeted cancer therapy market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

Global Small Molecule Targeted Cancer Therapy Market

The report provides company market share analysis in order to give a broader overview of the key players in the small molecule targeted cancer therapy market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the small molecule targeted cancer therapy market on global and regional basis.

The study provides a crucial view on the small molecule targeted cancer therapy by segmenting the market based on type, and region. All the segments of small molecule targeted cancer therapy market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Targeted cancer therapy uses drugs that specifically target cancer specific proteins, genes, tissue environment that assists in cancer cells’ growth and survival. These proteins or genes found in cancerous cells or blood vessel cells that are related to cancer growth. Targeted therapy uses signal transduction inhibitors, hormone therapies, angiogenesis inhibitors, apoptosis inducers, gene expression modulators, immunotherapies, monoclonal antibodies etc. Small molecule targeted therapy generally uses molecules of ≤5000 Da and are administered via oral route. Due to the small size, these molecules can easily translocate through the plasma membrane and can interact with intracellular signaling molecules and cell-surface receptors’ cytoplasmic domain.

The demand for small molecule targeted cancer therapy market is driven by growing preference for cancer therapies with minimal adverse events, increasing cancer prevalence and increasing awareness. Additionally, growing adoption of targeted therapy over chemotherapy, increasing health spending and disposable are important factors that boost the market growth. However, slower drug approval process, stringent regulatory requirements and high operational cost may limit the market growth over the forecast period. Patent expiry of major drugs is expected to bring growth opportunities over the forecast period for global small molecule targeted cancer therapy market.

Based on type, global small molecule targeted cancer therapy market is segmented into small molecule drug conjugates, small molecules and monoclonal antibodies. Small molecules type segment accounted for largest market share in 2018 due to its effectiveness and lesser side effects. Small molecules type segment is sub segmented into small molecule tyrosine kinase inhibitor, proteasome inhibitor and small molecule cyclin-dependent kinase inhibitor. Monoclonal antibodies segment is further split into humanized monoclonal antibody, chimeric monoclonal antibody and fully human antibody. Thus upper eyelid surgeries are most common and accounted for largest market share. Small molecule drug conjugates segment is projected to witness highest growth over the forecast period.

North America dominated the global small molecule targeted cancer therapy market in 2018. Increasing cancer prevalence, favorable reimbursement policies, presence of advanced health facilities, increasing health spending and increasing preference for therapies with minimal side effects are factors driving the market in this region. Europe was second largest regional small molecule targeted cancer therapy market. Growing awareness about cancer and advanced therapies, faster adoption of novel therapies are major factors that boost market growth in this region. Latin America is projected to exhibit moderate growth over the forecast period. Asia Pacific region will register highest CAGR for small molecule targeted cancer therapy market during the forecast period. Large population base, increasing cancer prevalence, growth in demand for targeted therapy with lesser side effects than chemotherapy, government initiatives to create awareness and increasing healthcare spending are factors promoting small molecule targeted cancer therapy market growth in Asia Pacific. Middle East and Africa region is estimated to show slower growth in coming years.

Major players included in the report are Abbott Laboratories, Bayer HealthCare AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Hospira Inc., Cytokinetics Inc. and OncoGenex Pharmaceuticals, Inc. among others.

The report segment of global small molecule targeted cancer therapy market as follows:

Global Small Molecule Targeted Cancer Therapy Market: By Type

  • Monoclonal Antibodies
    • Fully Human Antibody
    • Chimeric Monoclonal Antibody
    • Humanized Monoclonal Antibody
  • Small Molecules
    • Small Molecule Cyclin-dependent Kinase Inhibitor
    • Small Molecule Proteasome Inhibitor
    • Small Molecule Tyrosine Kinase Inhibitor
  • Small Molecule Drug Conjugates

Global Small Molecule Targeted Cancer Therapy Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Related Reports

Tissue Engineering Market by Application (Gynecology, Cell Banking & Cord blood, Dental, Urology, Integumentary & Skin, Cardiology, Neurology, Musculoskeletal, Orthopedics, & Spine, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5337 | Report Format:

The report covers forecast and analysis for the tissue engineering market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue engineering ma...Read More

Robotic Prosthetic Market by Extremity (Upper Body Prosthetics and Lower Body Prosthetics), and Technology (Myoelectric Prosthetics and MPC Prosthetics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5336 | Report Format:

The report covers forecast and analysis for the robotic prosthetic market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the robotic prosthetic ...Read More

Long-Term Care Market by Service (Hospice, Home Healthcare, Assisted Living Facilities, Nursing care, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5335 | Report Format:

The report covers forecast and analysis for the long-term care market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the long-term care market alo...Read More

Leprosy Treatment Market by Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), by Route of Administration (Oral, Injectable, Topical), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Mar-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5334 | Report Format:

The report covers forecast and analysis for the Leprosy Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Leprosy Treatment ma...Read More

Hunter Syndrome Treatment Market by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5333 | Report Format:

The report covers forecast and analysis for the hunter syndrome treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the hunter syndrom...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.